GSK picks McCann to launch cervical cancer vaccine in India

MUMBAI - GlaxoSmithKline (GSK) has selected McCann Healthcare Worldwide to drive the launch of cervical cancer vaccine Cervarix in the Indian market, following a pitch that included JWT, Ogilvy & Mather Healthcare and Sudler & Hennessey.

by David Blecken

Please sign in below or access limited articles a month after free, fast registration.

 If you don’t yet have an account, you can register for free to unlock additional content. For full access to everything we offer, view our subscription plans.

Register for free

✓ Access limited free articles each month

✓ Email bulletins – top industry news and insights delivered straight to your inbox

Register now

Subscribe

✓ Unlimited access to all Campaign Asia content

✓ Real-world campaign case studies and career insights

✓ Exclusive reports, industry news, and annual features

Join now